Cargando…

An observational study comparing the performance of TOF-Cuff with TOF-Scan monitoring during anaesthetic induction in clinical routine

Background: Neuromuscular monitoring by acceleromyography assesses the effects of non-depolarising neuromuscular blocking agents used during anaesthesia induction to optimise intubation conditions. A new type of neuromuscular monitor, TOF-Cuff, integrates electrode stimulation into a blood pressure...

Descripción completa

Detalles Bibliográficos
Autores principales: Markle, Andrew, Horn, Katja, Welter, JoEllen, Dullenkopf, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172956/
https://www.ncbi.nlm.nih.gov/pubmed/32876404
http://dx.doi.org/10.5114/ait.2020.98124
Descripción
Sumario:Background: Neuromuscular monitoring by acceleromyography assesses the effects of non-depolarising neuromuscular blocking agents used during anaesthesia induction to optimise intubation conditions. A new type of neuromuscular monitor, TOF-Cuff, integrates electrode stimulation into a blood pressure monitoring cuff. Comparisons of this device with TOF-Scan, considered a clinical standard acceleromyography device, have not been published. Methods: This prospective, observational study was approved by the Ethics Committee East Switzerland (BASEC-nr. 2016-02044), and patients’ consent was obtained before inclusion. The study’s aim was to compare TOF-Cuff with TOF-Scan by measuring the duration from the administration of a neuromuscular blocking agent to a train-of-four (TOF) ratio of 0%. After anaesthesia induction, atracurium was administered (0.5 mg kg(−1)) and TOF ratios were recorded every 15 seconds using the two devices simultaneously. Patients were grouped according to body mass index (< or ≥ 30 kg m(−2)). Results: Twenty-five non-obese and twenty-five obese patients were included. In non-obese patients, bias was −3 s (± 21.2; limits of agreement −44.7 to 38.4; P = 0.702). In obese patients, bias was −20 s (± 35.0; limits of agreement −88.6 to 48.6; P = 0.0139). Large intra-individual differences of up to 60 seconds were detected even in non-obese patients. Conclusions: A significant systematic difference in the time to reach a TOF ratio of 0% was found when using the two devices in obese patients. In non-obese and obese patients, there were large intra-individual and clinically relevant differences. The two devices cannot be used interchangeably.